Nicorandil Preserves Coronary Collateral Circulation Compared to Nitroglycerin Even in Systemic Hypotension: A Real-Time Myocardial Contrast Echocardiographic Study

Journal of Echocardiography

Volumn 2, Issue 4, 2004, Pages 90-98

  Iwata, Akiko ^a   Ishikura, Fuminobu ^a   Ohtani, Kentaro ^a   Toshida, Tsutomu ^a   Asanuma, Toshihiko ^a   Beppu, Shintaro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

collateral circulation; myocardial contrast echocardiography; nicorandil; nitroglycerin

Indexed keywords

EID: 33744538479     PISSN: 13490222     EISSN: 1880344X     Source Type: Journal    
DOI: 10.2303/jecho.2.90     Document Type: Article

References (34)

1. Shaper W, Frenzel H, Hort W. Experimental coronary occlusion, I. Measurement of infarct size. Basic Res Cardiol 1979; 74: 46–53.
2. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death, II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633–44.
3. Scheel KW, Mass H, Williams SE. Pressure-flow characteristics of coronary collaterals in dogs. Am J Physiol 1989; 256: H441-H445.
4. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473–83.
5. Masugata H, Peters B, Lafitte S, Strachan M, Ohmori K, DeMaria AN. Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refillng curves. J Am Coll Cardiol 2001; 37: 262–9.
6. Lafitte S, Masugata H, Peters B, Togni M, Strachan M, Kwan OL, et al. Comparative value of dobutamine and adenosine stress in the detection of coronary stenosis with myocardial contrast echocardiography. Circulation 2001; 103: 2724–30.
7. Lim YJ, Nanto S, Masuyama T, Kodama K, Kohama A, Kitabatake A, et al. Coronary collateral assessed with myocardial contrast echocardiography in healed myocardial infarction. Am J Cardiol 1990; 66: 556–61.
8. Sakata Y, Kodama K, Adachi T, Lim YJ, Ishikura F, Fuji H, et al. Comparison of myocardial contrast echocardiography and coronary angiography for assessing the acute protective effects of collateral recruitment during occlusion of the left anterior descending coronary artery at the time of elective angioplasty. Am J Cardiol 1997; 79: 1329–33.
9. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. Circulation 1992; 85: 2080–9.
10. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An Association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327: 1825–31.
11. Kemper AJ, Force T, Kloner R, Gilfoil M, Perkin L, Hale S, et al. Contrast echocardiographic estimation of regional myocardial blood flow after acute coronary occlusion. Circulation 1985; 72: 1115–24.
12. Kaul S, Pandian NG, Guerrero JL, Gillam LD, Okada RD, Weyman AE. Effects of selectively altering collateral driving pressure on regional perfusion and function in the occluded coronary bed in the dog. Circ Res 1987; 61: 77–85.
13. Cheirif J, Narkiewicz-Jodko JB, Hawkins HK, Bravenec JS, Quinones MA, Mickelson JK. Myocardial contrast echocardiography: Relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion. J Am Coll Cardiol 1995; 26: 537–46.
14. Coggins MP, Sklenar J, Le E, Wei K, Lindne JR, Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation 2001; 104: 2471–7.
15. Mills JD, Fisher D, Villanueva FS. Coronary collateral development during chronic ischemia: Serial assessment using harmonic myocardial contrast echocardiography. J Am Coll Cardiol 2000; 36: 618–24.
16. Grill HP, Brinkner JA, Taube JC, Walford GD, Midei MG, Flaherty JT, et al. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. J Am Coll Cardiol 1990; 16: 1594–1600.
17. Ha JW, Cho SY, Chung N, Choi DH, Choi BJ, Jang Y, et al. Fate of collateral circulation after successful coronary angioplasty of total occlusion assessed by coronary angiography and myocardial contrast echocardiography. J Am Soc Echocardiogr 2002; 15: 389–95.
18. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989; 63: 18J-24J.
19. Gross GJ, Pieper G, Warltier DC. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. J Cardiovasc Pharmacol 1987; 10 (Supple. 8): S76-S84.
20. Gross GJ, Warltier DC, Hardman HF. Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs. J Cardiovasc Pharmacol 1987; 10: 535–42.
21. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 1992; 20: 765–71.
22. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kazuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654–60.
23. The IONA study group. Effect of nicorandil on coronary artery in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) ramdamized trial. Lancet 2002; 359: 1269–75.
24. Shishido T, Beppu S, Matsuda H, Yutani C, Miyatake K. Extension of hemorrhage after reperfusion of occluded coronary artery: Contrast echocardiographic assessment in dogs. J Am Coll Cardiol 1997; 30: 585–91.
25. Jugdutt BI. Intravenous nitroglycerin unloading in acute myocardial infarction. Am J Cardiol 1991; 68: 52D-63D.
26. Jugdutt BI. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983; 68: 673–84.
27. Holzmann S, Kukovets WR, Braida C, Pöch G. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil. Eur J Pharmacol 1992; 215: 1–7.
28. Suryapranata H. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease. Eur Heart J 1993; 14 (suppl B): 16–21.
29. Krumenacker M, Roland E. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992; 20 (suppl 3): S93-S102.
30. Lamping KA, Gross GJ. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. J Cardiovasc Pharmacol 1984; 6: 601–8.
31. Lamping KA, Warltier DC, Hardman HF, Gross GJ. Effects of nicorandil, a new antianginal agent, and nifedipine a collateral blood flow in a chronic coronary occlusion model. J Pharmacol Exp There 1984; 229: 359–63.
32. Shiraki Y, Akima M, Nabata H, Ohba Y, Hoshino E, Sakai K. The hypotensive mechanisms of the new anti-anginal drug, N-(2-hydroxyethl) nicotinamide nitrate (SG-75) in beagle dogs. Japan. J. Pharmacol 1981; 31: 921–9.
33. Komaru T, Lamping KG, Eastham CL, Dellsperger KC. Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res 1991; 69: 1146–51.
34. Lamping KG, Bloom EN, Harrison DG. Regulation of native collateral vessel dilation after coronary occlusion in the dog. Am J Physiol 1994; 266: H769-H778.